Wei Liu

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center, Third Affiliated Hospital of Sun Yat-sen University, Liaoning Cancer Hospital & Institute, China Medical University · ORCID：0000-0002-5908-0661

发表论文 88 篇 · 总被引 699 次 · h-index 15

代表论文

• A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma (2022 · Translational Lung Cancer Research · 被引 20)
• A phase Ib/II, multicenter, open-label study of AK104, a PD-1/CTLA-4 bispecific antibody, combined with chemotherapy (chemo) as first-line therapy for advanced gastric (G) or gastroesophageal junction (GEJ) cancer. (2022 · Journal of Clinical Oncology · 被引 19)
• Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial (2021 · Advances in Therapy · 被引 19)
• A phase Ib/II, multicenter, open-label study of AK104, a PD-1/CTLA-4 bispecific antibody, combined with chemotherapy (chemo) as first-line therapy for advanced gastric (G) or gastroesophageal junction (GEJ) cancer: 2-Year update data. (2023 · Journal of Clinical Oncology · 被引 17)
• Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma (2021 · Annals of Surgery · 被引 15)
• TRIF-TAK1 signaling suppresses caspase-8/3-mediated GSDMD/E activation and pyroptosis in influenza A virus-infected airway epithelial cells (2024 · iScience · 被引 13)